✦ LIBER ✦

Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer

✍ Scribed by Yiqing Qu; Yie Yang; Baoyi Liu; Wei Xiao

Book ID: 107577004
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 359 KB
Volume: 27
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-009-9379-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determination of metastasis-associated p

Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis

✍ Tian Tian; Jia Hao; Anjian Xu; Juanting Hao; Chonglin Luo; Chuanjun Liu; Lingyun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

Economic evaluation of gemcitabine singl

Economic evaluation of gemcitabine single agent therapy compared with standard treatment in stage IIIB and IV non-small cell lung cancer

✍ Gunnel Ragnarson Tennvall; Jan-Olof Fernberg 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 978 KB

Expression of multidrug resistance-assoc

Expression of multidrug resistance-associated protein (MRP) and its relationship with clinicopathological factors in non-small cell lung cancer

✍ Jun Hao; Hui Wang; En-hua Wang; Xue-shan Qiu; Qing-chang Li; Yun-peng Liu 📂 Article 📅 2004 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 769 KB

Comparing the Relationship of Taxol-Base

Comparing the Relationship of Taxol-Based Chemotherapy Response with P-glycoprotein and Lung Resistance-Related Protein Expression in Non-Small Cell Lung Cancer

✍ J. -F. Chiou; J. -A. Liang; W. -H. Hsu; J. -J. Wang; S. -T. Ho; A. Kao 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 178 KB

A prospective, multicentre clinical tria

A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer

✍ Tuncay GOKSEL; Osman Nuri HATIPOGLU; Can OZTURK; Metin GORGUNER; Murat KIYIK; Ug 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Infiltrating immune cells, but not tumou

Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up

✍ Deirdre Toomey; Gordon Smyth; Claire Condron; James Kelly; Ann-Marie Byrne; Elai 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 261 KB 👁 1 views

## Abstract Non‐small cell lung cancer (NSCLC) remains a difficult disease to treat and independent prognostic markers other than tumour stage and histology have not emerged. The immune cell content of solid tumours has been associated with tumour regression and at times, tumour progression. The in